To Compare effect of Avipattikara Choorna And Tablet Ranitidine In The Management Of Urdhwag Amlapitta(Acid Peptic Disease)

Clinical Comparative Study Of Avipattikara Choorna And Tablet Ranitidine In The Management Of Urdhwag Amlapitta(Acid Peptic Disease). - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/03/105128

Enrollment

Registered

2026-03-02

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K273- Acute peptic ulcer, site unspecified, without hemorrhage or perforation Health Condition 2: K219- Gastro-esophageal reflux disease without esophagitis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patient willing for clinical trial study. 2) Age group-20-60 years. 3) Sex-Both Female & male. 4) Patients having symptoms of Urdhwaga amlpitta mentioned in Ancient text.

Exclusion criteria

Exclusion criteria: 1) Patients aged below 20 years and above 60 years will be excluded. 2) Patient not willing for clinical trial. 3) Patients suffering from any other chronic systemic disorders. 4) Any other addictions like chronic alcoholism induced hyperacidity. 5) Patient suffering from gastric ulcer.

Design outcomes

Primary

Measure	Time frame
Assess and compare the efficacy of Avipattikara choorna and Tablet Ranitidine in the management of Urdhwag AmlapittaTimepoint: 21 days	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr Ronak Rajaram Ranage

Ashvin Rural Ayurved College and Hospital Manchi Hill

dr.abhijitgaikwad3184@gmail.com9890101445

Outcome results